Switzerland-Taiwan Biotech Leaders Virtual Forum


Jul. 16th, 2020

10:00-11:00  AM (CEST, 歐洲中部夏令時間)
04:00-05:00  PM (Taiwan Time, 臺灣時間)

Venue:  Zoom Virtual Meeting

Covid19 pandemic has created an unprecedented impact on the biotech industry around the globe. At the same time, such a crisis also provides opportunities to unite the industry and sparks extraordinary cooperation for finding therapeutics. 
In this event, experts from Switzerland and Taiwan will sit together remotely and share their views on:
  • The most critical impact of covid19 pandemic on biotech industries in Switzerland and Taiwan
  • Innovative measures that the industry has taken during the crisis and the new normality
  • Opportunities to collaborate and form a more resilient biotech alliance in the future  
Invited Speakers
  • Michael Altorfer
    CEO, Swiss Biotech Association
  • Johnsee Lee 李鍾熙
    Chairman, Taiwan Bio Industry Organization
  • John Tsai
    Head of Global Drug Development and Chief Medical Officer, Novartis
  • Shiing-Jer Twu 涂醒哲
    Chairman, Development Center for Biotechnology

Thomas Brenzikofer
Co-Founder and Manager, DayOne, Basel Area Business & Innovation

Background image designed by kjpargeter / Freepik


Time Topics Speakers
10:00 – 10:10 Welcome Notes & Speakers Introduction Dr. Linus Kao
Europe-Taiwan Biotech Association
10:10 – 10:45 Panel Discussion Dr. Michael Altorfer
Swiss Biotech AssociationDr. Johnsee Lee 李鍾熙
Taiwan Bio Industry Organization

Dr. med. John Tsai
Head of Global Drug Development and Chief Medical Officer
Novartis Pharma

Dr. Shiing-Jer Twu 涂醒哲
Development Center for Biotechnology

Thomas Brenzikofer
Co-Founder and Manager
DayOne, Basel Area Business & Innovation

10:45 – 11:00 Q&A